NEW YORK (GenomeWeb News) – Thermo Fisher Scientific this week said that it has acquired Doe & Ingalls Management, a provider of production chemicals and customized supply chain services to the life sciences and microelectonic industries, for approximately $175 million in cash. The acquired firm, which had revenues of $110 million in 2011, will become part of Thermo Fisher's customer channels business within its Laboratory Products and Services segment.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: transcript patterns in drug-resistant cancer cells, function of high-altitude adaption gene, and more.

Monitoring gene expression changes could help sniff out athletes using performance-enhancing drugs, New Scientist says.

The University of Southern California lodges a cross-complaint in its legal dispute with the University of California, San Diego, over a large Alzheimer's disease project.

In PLOS this week: gene fusion in premature ovarian failure, population patterns in the Franciscana dolphin, and more.